Ongoing clinical trials are measuring IL‐6 in relation to ischemic stroke prognosis (NCT05004389; NCT03297827), ischemic stroke treatment efficacy (NCT04705779), hemorrhagic stroke recovery using in‐bed cycle ergometry (NCT04027049), and even IS and HS recovery following autologous mesenchymal stem cell therapy (NCT04063215). This evidence concerns the gene IL6 and ischemic stroke.